| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |